The Oxford vaccine, developed in tandem with AstraZeneca, has so far been covered in the press as a “game-changing” contribution to the coronavirus crisis: cheaper than the mRNA vaccines developed by Moderna and BNT-Pfizer and just as effective and easier to distribute (the vaccine can be stored at fridge temperature).